Mr. Rivas joined R1 RCM in June following the company’s acquisition of revenue recovery provider and consultant Cloudmed. Mr. Rivas was Cloudmed’s CEO.
Mr. Flanagan will continue to serve as a member of R1 RCM’s board, according to a Nov. 8 news release from the company. As part of the succession process, Mr. Flanagan will also serve as an executive adviser to the CEO.
R1 RCM Chief Operating Officer John Sparby will step into the role of president, according to the release. Mr. Sparby joined the company in 2004.
Mr. Flanagan joined R1 RCM in 2013 as COO.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
